Sep 6 2011
Concentric Medical, Inc. today announced the full European launch of Trevo® Pro 4 System. This next standard in Stentriever™ technology has an enhanced design to further promote clot integration across clot types in patients suffering an acute ischemic stroke.
The Trevo® Pro 4 system is the next generation of Trevo Stentrievers from Concentric Medical and is used to remove thrombus in stroke patients. It has a unique wide-cell geometry allowing the clot to more easily incorporate in the device. This unique cell and strut architecture, coupled with its proven radial force profile, are designed to further enhance clot retrieval in all clot types with fewer passes of the device in the procedure.
The Trevo Pro 4 device was introduced to a limited number of leading stroke centers in the spring. Fifty cases were completed in an initial evaluation post CE mark with very positive feedback from clinicians in Europe.
"The Trevo® Pro 4 System is a significant advance in the field of mechanical thrombectomy. I have had the opportunity to utilize this device in many procedures and have found the clot integration astonishing, regardless of the complexity of the clot. On many occasions I have achieved revascularization with one pass of the device," said Professor Olav Jansen, Head of Neuroradiology at Universitatsklinikum Schleswig-Holstein, Kiel, Germany.
Maria Sainz, President and CEO of Concentric Medical, also commented: "The Trevo Pro System has improved the predictability of the interventional stroke procedure for physicians. The device redefines the standard for success for physicians and patients. Concentric Medical is very proud to be able to offer the latest advancement in Trevo technology along with a full array of complementary tools for the entire stroke interventional procedure."
Study finds varying cardiovascular risks associated with different hormonal contraceptives